Table 2. NECPAL+ patient distribution by characteristics and hospital.
| Total NECPAL+ (n = 681) | Lanari Institute (n = 205) | Roffo Institute (n = 118) | Udaondo Hospital (n = 358) | ||||
|---|---|---|---|---|---|---|---|
| Inpatient (n = 75) | Outpatient (n = 130) | Inpatient (n = 27) | Outpatient (n = 91) | Inpatient (n = 43) | Outpatient (n = 315) | ||
| Female | 339 (50%) | 35 (47%) | 72 (56%) | 9 (33%) | 53 (59%) | 19 (44%) | 150 (48%) |
| Age (mean) | 65 (23–99) | 76 (50–93) | 76 (38–99) | 56 (27–77) | 63 (33–81) | 60 (32–99) | 59 (23–91) |
| Nutritional decline | 259 (38%) | 42 (56%) | 37 (29%) | 10 (37%) | 19 (21%) | 23 (53%) | 128 (41%) |
| Functional decline | 266 (39%) | 54 (72%) | 66 (51%) | 18 (67%) | 33 (37%) | 17 (40%) | 76 (24%) |
| Functional dependence | 89 (13%) | 24 (32%) | 17 (13%) | 8 (30%) | 5 (6%) | 7 (16%) | 27 (9%) |
| Breast cancer | 36 (5%) | 7 (9%) | 24 (19%) | 4 (15%) | 1 (1%) | 0 (0%) | 0 (0%) |
| Lung cancer | 118 (17%) | 8 (11%) | 23 (18%) | 3 (11%) | 83 (92%) | 0 (0%) | 1 (0%) |
| Gastrointestinal cancer | 413 (61%) | 31 (41%) | 25 (19%) | 7 (26%) | 1 (1%) | 43 (100%) | 305 (97%) |
| Genitourinary cancer | 35 (5%) | 8 (11%) | 22(17%) | 2 (7%) | 3 (3%) | 0 (0%) | 0 (0%) |
| Oncohaematologic | 11 (2%) | 5 (7%) | 6 (5%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Gynaecologic cancer | 12 (2%) | 1 (1%) | 7 (5%) | 4 (15%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Other | 40 (6%) | 9 (12%) | 19 (15%) | 7 (26%) | 2 (2%) | 0 (0%) | 3 (1%) |
| Primary Unknown | 16 (2%) | 6 (8%) | 3 (2%) | 0 (0%) | 0 (0%) | 0 (0%) | 6 (2%) |